DBVT's outstanding shares more than doubled from 137M to 296M while current liabilities surged 86% and net losses widened to $147M, indicating significant dilution and deteriorating financial position despite advancing toward BLA submission.
The massive 116% increase in outstanding shares represents severe dilution for existing shareholders, likely from equity raises to fund operations. Combined with exploding current liabilities and widening losses, this suggests the company is burning through cash rapidly as it approaches its critical BLA filing milestone for Viaskin Peanut Patch.
The financial picture shows a company under significant strain with current liabilities jumping 86% to $58M and operating losses expanding 26% to $147M, while R&D expenses increased 31% to $117M. Despite 36% revenue growth to $5.6M, the company appears to be funding operations through dilutive equity raises (evidenced by the share count doubling) and has dramatically reduced capital expenditures by 77%. The overall trajectory suggests mounting financial pressure as DBVT races toward its pivotal BLA submission deadline in the first half of 2026.
Current liabilities surged 86.4% — significant near-term obligations; verify ability to meet short-term debt.
Capex reduced 77.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Liabilities grew 69.7% — significant increase in debt or obligations, assess impact on financial flexibility.
Debt reduced 59.7% — deleveraging strengthens balance sheet and reduces financial risk.
Strong top-line growth of 35.8% — accelerating demand or successful expansion into new markets.
R&D investment increased 30.6% — signals commitment to future product development, though near-term margin impact.
Net income declined 29% — review whether driven by operations, interest costs, or non-recurring items.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →